Clinical Trial: A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Obesity or Overweight
Study Type: INTERVENTIONAL
Official Title: Efficacy and Safety of Cagrilintide S.C. 2.4 mg in Combination With Semaglutide S.C. 2.4 mg (CagriSema S.C. 2.4 mg/2.4 mg) Once-Weekly in East Asian Participants With Overweight or Obesity
Brief Summary:
This study will look at how well the new medicine CagriSema helps people with excess body weight lose weight compared to another medicine, semaglutide.The participants will receive one injection once a week.The study medicine will be injected with a thin needle, typically in the stomach, thighs or upper arms.The study will last for about 1½ years.
Read more